Infection in breast implants

Lancet Infectious Diseases

Volumn 5, Issue 2, 2005, Pages 94-106

  Pittet, Brigitte ^a   Montandon, Denys ^a   Pittet, Didier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACITRACIN; CEFALOTIN; CEPHALOSPORIN; FORMALDEHYDE; GENTAMICIN; GRAMICIDIN; MINOCYCLINE; NEOMYCIN; NEOSPORIN; NYLON; POLITEF; POLYETHER DERIVATIVE; POLYETHYLENE; POLYMER; POLYMYXIN; POLYPROPYLENE; POLYURETHAN; POLYVINYL ALCOHOL; POLYVINYL ALCOHOL SPONGE; POVIDONE IODINE; RIFAMPICIN; SILICONE GEL; SODIUM CHLORIDE; STEROID;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTEREMIA; BREAST AUGMENTATION; BREAST CANCER; BREAST ENDOPROSTHESIS; BREAST RECONSTRUCTION; CANCER RADIOTHERAPY; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTRACTURE; DEVICE REMOVAL; DISEASE CLASSIFICATION; DISINFECTION; ECHOGRAPHY; GRANULOMA; HISTOPATHOLOGY; HISTORY; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; LAVAGE; MASTECTOMY; MICROBIAL CONTAMINATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROFLORA; MORBIDITY; NONHUMAN; PEROPERATIVE CARE; PLASTIC SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTHESIS INFECTION; REIMPLANTATION; REVIEW; RISK FACTOR; SKIN; SURGICAL DRAINAGE; SURGICAL INFECTION; SURGICAL TECHNIQUE; SYSTEMIC SCLEROSIS; TOXIC SHOCK SYNDROME;

EID: 12944323705     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70084-0     Document Type: Review

References (176)

1. Cook RR, Perkins LL. The prevalence of breast implants among women in the United States. Curr Top Microbiol Immunol. 210:1996;419-425
2. Herdman RC, Fahey TJ Jr. Silicone breast implants and cancer. Cancer Invest. 19:2001;821-832
3. Bondurant S, Ernster V, Herdman RC, eds. Safety of silicone breast implants. Washington, DC: National Academy Press, 1999.
4. Medicines and Healthcare Products Regulatory Agency. UK Breast Implant Registry: annual report 2002. London: Department of Health, 2004: 1-36 (in press).
5. Demargne P. Naissance de l'Art Grec. In: Malraux A, ParrotA, eds. L'Univers des Formes (no. 6), 2nd edn. Paris: Gallimard, 1974: 102.
6. Grazer F, Klingbeil J. Body image: a surgical perspective. 1980;Mosby, St Louis
7. Sarwer DB, Nordmann JE, Herbert JD. Cosmetic breast augmentation surgery: a critical overview. J Womens Health Gend Based Med. 9:2000;843-856
8. Yalom M. A history of the breast. 1997;AA Knopf, New York
9. Fallon A. Culture in the mirror: sociocultural determinants of body image. Cash T, Pruzinsky T. Body images: development, deviance and change. 1990;80 Guilford Press, New York
10. Haiken E. Venus envy: a history of cosmetic surgery. 1997;Johns Hopkins University Press, Baltimore
11. Czerny V. Plastischer Erzats de Brustdruse durch ein Lipom [abstract]. Zentralbl Chir. 27:1895;72
12. Broadbent TR, Woolf RM. Augmentation mammaplasty. Plast Reconstr Surg. 40:1967;517-523
13. Gersuny R. Harte und wieche praffinprothesen. Zentralbl Chir. 30:1903;1-5
14. Morestin H. Inconvénients et abus des injections de paraffine. Bull Soc Chir (Paris). 34:1908;124-128
15. Kach F. Uber gelegentliche Gefärhe kostmetischen Paraffin Injektion. Munch Med Wochenschr. 34:1919;965-967
16. Bettmann H. Uber Folgeerscheinugen subcutaner Paraffininjektionen. Berl Klin Wochenschr. 22:1922;1040-1041
17. Bondurant S, Ernster V, Herdman RC, eds. Safety of silicone breast implants. Washington, DC: National Academy Press, 2000.
18. Boo-Chai K. The complications of augmentation mammaplasty by silicone injection. Br J Plast Surg. 22:1969;281-285
19. Ortiz-Monasterio F, Trigos I. Management of patients with complications from injections of foreign materials into the breasts. Plast Reconstr Surg. 50:1972;42-47
20. Vinnick C. Silicone mastopathy. Owsley JQ, Peterson RA. Symposium on aesthetic surgery of the breast. 1978;151-155 Mosby, St Louis
21. Franklyn RA. Beauty surgeon. 1960;239 Whitehorn, Long Beach
22. Pangman WJ, Wallace RM. The use of plastic prosthesis in breast plastic and other soft tissue surgery. West J Surg Obstet Gynecol. 63:1955;503-512
23. Neuman Z. The use of the non-absorbable polyethylene sponge, "Polystan sponge", as a subcutaneous prosthesis (an experimental study in rats). Br J Plast Surg. 9:1957;195-199
24. Arons M, Sabesin S, Sith R. Experimental studies with Etheron sponge. Plast Reconstr Surg. 28:1961;72-80
25. Edgerton MT, Meyer E, Jacobson WE. Augmentation mammaplasty. II. Further surgical and psychiatric evaluation. Plast Reconstr Surg. 27:1961;279-302
26. Harris HI. Survey of breast implants from the point of view of carcinogenesis. Plast Reconstr Surg. 28:1961;81-83
27. Cronin T, Gerow F. Augmentation mammaplasty: a new "natural feel" prosthesis. Broadbent TR. Transactions of the Third International Congress of Plastic and Reconstructive Surgery. 1963;41-49 Excerpta Medica Foundation, Amsterdam
28. Cronin TD, Greenberg RL. Our experiences with the silastic gel breast prosthesis. Plast Reconstr Surg. 46:1970;1-7
29. Young VL, Watson ME. Breast implant research: where we have been, where we are, where we need to go. Clin Plast Surg 2001; 28: 451-83, vi.
30. Byron MA, Venning VA, Mowat AG. Post-mammoplasty human adjuvant disease. Br J Rheumatol. 23:1984;227-229
31. Van Nunen S, Gatenby P, Basten A. Post-mammoplasty connective tissue disease. Arthritis Rheum. 25:1982;694
32. Baldwin CM Jr, Kaplan EN. Silicone-induced human adjuvant disease? Ann Plast Surg. 10:1983;270-273
33. Loeser E. Long-term toxicity and carcinogenicity studies with 2,4/2,6-toluene-diisocyanate (80/20) in rats and mice. Toxicol Lett. 15:1983;71-81
34. Reynolds HE. Evaluation of the augmented breast. Radiol Clin North Am. 33:1995;1131-1145
35. Thornton JW, Argenta LC, McClatchey KD, Marks MW. Studies on the endogenous flora of the human breast. Ann Plast Surg. 20:1988;39-42
36. Courtiss EH, Goldwyn RM, Anastasi GW. The fate of breast implants with infections around them. Plast Reconstr Surg. 63:1979;812-816
37. Middleton MS. Magnetic resonance evaluation of breast implants and soft-tissue silicone. Top Magn Reson Imaging. 9:1998;92-137
38. Wilkinson T. Breast augmentation by periareolar incisions. Georgiade N. Aesthetic breast surgery. 1983;71-86 Williams & Wilkins, Baltimore
39. Neifert M, DeMarzo S, Seacat J, Young D, Leff M, Orleans M. The influence of breast surgery, breast appearance, and pregnancy-induced breast changes on lactation sufficiency as measured by infant weight gain. Birth. 17:1990;31-38
40. Barton F, Tebbetts J. Augmentation mammaplasty. Selected Readings in Plastic Surgery. 5:1989;1-26
41. Gylbert L, Asplund OA, Jurell G. Capsular contracture after breast reconstruction with silicone-gel and saline filled implants: a 6-year follow-up. Plast Reconstr Surg. 85:1990;373-377
42. Fock KM, Feng PH. Connective tissue disease after augmentation mammoplasty. Arthritis Rheum. 27:1984;1440
43. Fock KM, Feng PH, Tey BH. Autoimmune disease developing after augmentation mammoplasty: report of 3 cases. J Rheumatol. 11:1984;98-100
44. Okano Y, Nishikai M, Sato A. Scleroderma, primary biliary cirrhosis, and Sjogren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann Rheum Dis. 43:1984;520-522
45. Weiner SR, Paulus HE. Chronic arthropathy occurring after augmentation mammaplasty. Plast Reconstr Surg. 77:1986;185-192
46. Sergott TJ, Limoli JP, Baldwin CM Jr, Laub DR. Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg. 78:1986;104-114
47. Spiera H. Scleroderma after silicone augmentation mammoplasty. JAMA. 260:1988;236-238
48. Varga J, Schumacher HR, Jimenez SA. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med. 111:1989;377-383
49. Marik PE, Kark AL, Zambakides A. Scleroderma after silicone augmentation mammoplasty. A report of 2 cases. S Afr Med J. 77:1990;212-213
50. Sahn EE, Garen PD, Silver RM, Maize JC. Scleroderma following augmentation mammoplasty. Report of a case and review of the literature. Arch Dermatol. 126:1990;1198-1202
51. Spiera H, Kerr LD. Scleroderma following silicone implantation: a cumulative experience of 11 cases. J Rheumatol. 20:1993;958-961
52. Copeland M, Kressel A, Spiera H, Hermann G, Bleiweiss IJ. Systemic inflammatory disorder related to fibrous breast capsules after silicone implant removal. Plast Reconstr Surg. 92:1993;1179-1181
53. Kessler DA. Special report: the basis of the FDA's decision on breast implants. N Engl J Med. 326:1992;1713-1715
54. Kjoller K, Friis S, Mellemkjaer L, et al. Connective tissue disease and other rheumatic conditions following cosmetic breast implantation in Denmark. Arch Intern Med. 161:2001;973-979
55. Weisman MH, Vecchione TR, Albert D, Moore LT, Mueller MR. Connective-tissue disease following breast augmentation: a preliminary test of the human adjuvant disease hypothesis. Plast Reconstr Surg. 82:1988;626-630
56. Schusterman MA, Kroll SS, Reece GP, et al. Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report. Ann Plast Surg. 31:1993;1-6
57. Englert HJ, Brooks P. Scleroderma and augmentation mammoplasty - a causal relationship? Aust N Z J Med. 24:1994;74-80
58. Gabriel SE, O'Fallon WM, Kurland LT, Beard CM, Woods JE, Melton LJ 3rd. Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 1994; 330: 1697-702.
59. Giltay EJ, Bernelot Moens HJ, Riley AH, Tan RG. Silicone breast prostheses and rheumatic symptoms: a retrospective follow up study. Ann Rheum Dis. 53:1994;194-196
60. McLaughlin JK, Fraumeni JF Jr, Olsen J, Mellemkjaer L. Re: Breast implants, cancer, and systemic sclerosis. J Natl Cancer Inst. 86:1994;1424
61. Strom BL, Reidenberg MM, Freundlich B, Schinnar R. Breast silicone implants and risk of systemic lupus erythematosus. J Clin Epidemiol. 47:1994;1211-1214
62. Wells KE, Cruse CW, Baker JL Jr, et al. The health status of women following cosmetic surgery. Plast Reconstr Surg. 93:1994;907-912
63. Goldman JA, Greenblatt J, Joines R, White L, Aylward B, Lamm SH. Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. J Clin Epidemiol. 48:1995;571-582
64. Sanchez-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speizer FE, Liang MH. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med. 332:1995;1666-1670
65. Burns CJ, Laing TJ, Gillespie BW, et al. The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol. 23:1996;1904-1911
66. Hennekens CH, Lee IM, Cook NR, et al. Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA. 275:1996;616-621
67. Hochberg MC, Perlmutter DL, Medsger TA Jr, et al. Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum. 39:1996;1125-1131
68. Friis S, Mellemkjaer L, McLaughlin JK, et al. Connective tissue disease and other rheumatic conditions following breast implants in Denmark. Ann Plast Surg. 39:1997;1-8
69. Williams HJ, Weisman MH, Berry CC. Breast implants in patients with differentiated and undifferentiated connective tissue disease. Arthritis Rheum. 40:1997;437-440
70. Edworthy SM, Martin L, Barr SG, Birdsell DC, Brant RF, Fritzler MJ. A clinical study of the relationship between silicone breast implants and connective tissue disease. J Rheumatol. 25:1998;254-260
71. Nyren O, Yin L, Josefsson S, et al. Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ. 316:1998;417-422
72. Park AJ, Black RJ, Sarhadi NS, Chetty U, Watson AC. Silicone gel-filled breast implants and connective tissue diseases. Plast Reconstr Surg. 101:1998;261-268
73. Brown SL, Pennello G, Berg WA, Soo MS, Middleton MS. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J Rheumatol. 28:2001;996-1003
74. US FDA, Center for Devices and Radiological Health. Draft guidance for industry and FDA staff: saline, silicone gel, and alternative breast implants (issued Jan 13, 2004). http://www.fda.gov/cdrh/ode/guidance/1239.html (accessed Dec 19, 2004).
75. The Independent Review Group. Silicone gel breast implants: the report of the independent review group. London: Crown Copyright, 1998. http://www.silicone-review.gov.uk (accessed Jan 3, 2005).
76. Hulka D. Epidemiological analysis of silicone breast implants and connective tissue disease: National Science Panel, 1998: Report of the National Science Panel. 1998;Little Brown & Company, London
77. Tugwell P, Wells G, Peterson J, et al. Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national science panel. Arthritis Rheum. 44:2001;2477-2484
78. European Parliament Directorate General for Research, Scientific and Technical Options Assessment. Health risks posed by sililcone implants in general, with special attention to breast implants. 2000;European Parliament, Luxembourg
79. European Committee on Quality Assurance and Medical Devices in Plastic Surgery. Consensus declaration on breast implants. Fourth consensus declaration. 2000;European Committee on Quality Assurance, Herzliya
80. European Committee on Quality Assurance and Medical Devices in Plastic Surgery. Consensus declaration of EQUAM. Fifth consensus declaration. 2002;European Committee on Quality Assurance, Groningen
81. European Committee for Standardization. Body contouring implants: specific requirements for mammary implants. Delft, Nederlands: Normalisatie-instituut, 2003. CEN/TC 285 WG 6 TF1. http://europa.eu.int/comm/ enterprise/medical_devices/index.htm (accessed Jan 3, 2005).
82. The Commission of the European Communities. Commission directive 2003/12/EC of 3 February 2003 on the reclassification of breast implants in the framework of directive 93/42/EEC concerning medical devices. 2003;Official Journal of the European Union, Brussels
83. Brinton L, Lubin J, Burich M, Colton T, Brown S, Hoover R. Breast cancer following augmentation mammoplasty (United States). Cancer Causes Control. 11:2000;819-827
84. Skinner A, Silberman H, Dougherty W, et al. Breast cancer after augmentation mammaplasty. Ann Surg Oncol. 8:2001;138-144
85. Miglioretti D, Rutter C, Geller B, et al. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA. 291:2004;442-450
86. Kjoller K, Holmich LR, Jacobsen PH, et al. Epidemiological investigation of local complications after cosmetic breast implant surgery in Denmark. Ann Plast Surg. 48:2002;229-237
87. Stein Z. Silicone breast implants: epidemiological evidence of sequelae. Am J Public Health. 89:1999;484-487
88. Brown SL. Epidemiology of silicone-gel breast implants. Epidemiology. 13:(suppl):2002;S34-S39
89. De Cholnoky T. Augmentation mammaplasty. Survey of complications in 10,941 patients by 265 surgeons. Plast Reconstr Surg. 45:1970;573-577
90. Mladick RA. No-touch" submuscular saline breast augmentation technique. Aesthetic Plast Surg. 17:1993;183-192
91. Cocke WM Jr. A critical review of augmentation mammoplasty with saline-filled prostheses. Ann Plast Surg. 32:1994;266-269
92. Clegg HW, Bertagnoll P, Hightower AW, Baine WB. Mammaplasty-associated mycobacterial infection: a survey of plastic surgeons. Plast Reconstr Surg. 72:1983;165-169
93. Rheingold LM, Yoo RP, Courtiss EH. Experience with 326 inflatable breast implants. Plast Reconstr Surg. 93:1994;118-122
94. Capozzi A. Clinical experience with Heyer-Schulte inflatable implants in breast augmentation. Plast Reconstr Surg. 77:1986;772-778
95. Armstrong RW, Berkowitz RL, Bolding F. Infection following breast reconstruction. Ann Plast Surg. 23:1989;284-288
96. Gabriel SE, Woods JE, O'Fallon WM, Beard CM, Kurland LT, Melton LJ 3rd. Complications leading to surgery after breast implantation. N Engl J Med 1997; 336: 677-82.
97. Brown SL, Hefflin B, Woo EK, Parmentier CM. Infections related to breast implants reported to the Food and Drug Administration, 1977-1997. J Long Term Eff Med Implants. 11:2001;1-12
98. Schatten WE. Reconstruction of breasts following mastectomy with polyurethane-covered, gel-filled prostheses. Ann Plast Surg. 12:1984;147-156
99. Hester TR Jr, Nahai F, Bostwick J, Cukic J. A 5-year experience with polyurethane-covered mammary prostheses for treatment of capsular contracture, primary augmentation mammoplasty, and breast reconstruction. Clin Plast Surg. 15:1988;569-585
100. Schlenker JD, Bueno RA, Ricketson G, Lynch JB. Loss of silicone implants after subcutaneous mastectomy and reconstruction. Plast Reconstr Surg. 62:1978;853-861
101. Capozzi A, Pennisi VR. Clinical experience with polyurethane-covered gel-filled mammary prostheses. Plast Reconstr Surg. 68:1981;512-520
102. Eyssen JE, von Werssowetz AJ, Middleton GD. Reconstruction of the breast using polyurethane-coated prostheses. Plast Reconstr Surg. 73:1984;415-421
103. Slade CL. Subcutaneous mastectomy: acute complications and long-term follow-up. Plast Reconstr Surg. 73:1984;84-90
104. Jabaley ME, Das SK. Late breast pain following reconstruction with polyurethane-covered implants. Plast Reconstr Surg. 78:1986;390-395
105. Herman D, Wilk A, Meyer C, Rodier-Bruant C, Kolbe A. Our experience of infectious risk in prosthetic breast surgery. Agressologie. 33:1992;188-190. (in French)
106. Nahabedian MY, Tsangaris T, Momen B, Manson PN. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg. 112:2003;467-476
107. Worton E, Siefert L. Augmentation mammaplasty: a review of fifty consecutive patients. Owsley JQ, Peterson RA. Symposium on aesthetic surgery of the breast. 1978;341-343 Mosby, St Louis
108. Vandeweyer E, Deraemaecker R, Nogaret JM, Hertens D. Immediate breast reconstruction with implants and adjuvant chemotherapy: a good option? Acta Chir Belg. 103:2003;98-101
109. Brand KG. Infection of mammary prostheses: a survey and the question of prevention. Ann Plast Surg. 30:1993;289-295
110. Young VL, Hertl MC, Murray PR, Jensen J, Witt H, Schorr MW. Microbial growth inside saline-filled breast implants. Plast Reconstr Surg. 100:1997;182-196
111. Young VL, Hertl MC, Murray PR, Lambros VS. Paecilomyces variotii contamination in the lumen of a saline-filled breast implant. Plast Reconstr Surg. 96:1995;1430-1434
112. Chen NT, Butler PE, Hooper DC, May JW Jr. Bacterial growth in saline implants: in vitro and in vivo studies. Ann Plast Surg. 36:1996;337-341
113. Liang MD, Narayanan K, Ravilochan K, Roche K. The permeability of tissue expanders to bacteria: an experimental study. Plast Reconstr Surg. 92:1993;1294-1297
114. Javaid M, Shibu M. Breast implant infection following nipple piercing. Br J Plast Surg. 52:1999;676-677
115. McGrath MH, Burkhardt BR. The safety and efficacy of breast implants for augmentation mammaplasty. Plast Reconstr Surg. 74:1984;550-560
116. Dolsky RL. Polyurethane-coated implants. Plast Reconstr Surg. 76:1985;974-975
117. Ahn CY, Ko CY, Wagar EA, Wong RS, Shaw WW. Microbial evaluation: 139 implants removed from symptomatic patients. Plast Reconstr Surg. 98:1996;1225-1229
118. Barnett A, Lavey E, Pearl RM, Vistnes LM. Toxic shock syndrome from an infected breast prosthesis. Ann Plast Surg. 10:1983;408-410
119. Freedman AM, Jackson IT. Infections in breast implants. Infect Dis Clin North Am. 3:1989;275-287
120. Holm C, Muhlbauer W. Toxic shock syndrome in plastic surgery patients: case report and review of the literature. Aesthetic Plast Surg. 22:1998;180-184
121. Walker LE, Breiner MJ, Goodman CM. Toxic shock syndrome after explantation of breast implants: a case report and review of the literature. Plast Reconstr Surg. 99:1997;875-879
122. Bartlett P, Reingold AL, Graham DR, et al. Toxic shock syndrome associated with surgical wound infections. JAMA. 247:1982;1448-1450
123. Knudsen F, Olesen AS, Hojbjerg T, Jorgensen JP, Nielsen KK. Toxic shock syndrome. Br Med J (Clin Res Ed). 282:1981;399
124. Giesecke J, Arnander C. Toxic shock syndrome after augmentation mammaplasty. Ann Plast Surg. 17:1986;532-533
125. Tobin G, Shaw RC, Goodpasture HC. Toxic shock syndrome following breast and nasal surgery. Plast Reconstr Surg. 80:1987;111-114
126. Olesen LL, Ejlertsen T, Nielsen J. Toxic shock syndrome following insertion of breast prostheses. Br J Surg. 78:1991;585-586
127. Poblete JV, Rodgers JA, Wolfort FG. Toxic shock syndrome as a complication of breast prostheses. Plast Reconstr Surg. 96:1995;1702-1708
128. Wallace RJ Jr, Steele LC, Labidi A, Silcox VA. Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. J Infect Dis. 160:1989;281-288
129. Clegg HW, Foster MT, Sanders WE Jr, Baine WB. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features. J Infect Dis. 147:1983;427-433
130. Heistein JB, Mangino JE, Ruberg RL, Bergese JJ. A prosthetic breast implant infected with Mycobacterium fortuitum. Ann Plast Surg. 44:2000;330-333
131. Haiavy J, Tobin H. Mycobacterium fortuitum infection in prosthetic breast implants. Plast Reconstr Surg. 109:2002;2124-2128
132. Safranek TJ, Jarvis WR, Carson LA, et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med. 317:1987;197-201
133. Gibney J. The long-term results of tissue expansion for breast reconstruction. Clin Plast Surg. 14:1987;509-518
134. Gnanadesigan N, Pechter EA, Mascola L. Listeria infection of silicone breast implant. Plast Reconstr Surg 1994; 94: 531-33, discussion 534-35.
135. Hunger J, Padilla M, Cooper-Vastola S. Late Clostridium perfringens breast implant infections after dental treatment. Ann Plast Surg. 36:1996;309-312
136. Niazi ZB, Salzberg CA, Montecalvo M. Candida albicans infection of bilateral polyurethane-coated silicone gel breast implants. Ann Plast Surg. 37:1996;91-93
137. Bernardi C, Saccomanno F. Late Klebsiella pneumoniae infection following breast augmentation: case report. Aesthetic Plast Surg. 22:1998;222-224
138. Ablaza VJ, LaTrenta GS. Late infection of a breast prosthesis with Enterococcus avium. Plast Reconstr Surg. 102:1998;227-230
139. Petit F, Maladry D, Werther JR, Mitz V. Late infection of breast implant, complication of colonic perforation. Review of the literature. Role of preventive treatment. Ann Chir Plast Esthet. 43:1998;559-562. (in French)
140. Eliopoulos DA, Lyle G. Mycobacterium avium infection in a patient with the acquired immunodeficiency syndrome and silicone breast implants. South Med J. 92:1999;80-83
141. Johnson LB, Busuito MJ, Khatib R. Breast implant infection in a cat owner due to Pasteurella multocida. J Infect. 41:2000;110-111
142. Memish ZA, Alazzawi M, Bannatyne R. Unusual complication of breast implants: brucella infection. Infection. 29:2001;291-292
143. Reddy BT, Torres HA, Kontoyiannis DP. Breast implant infection caused by Trichosporon beigelii. Scand J Infect Dis. 34:2002;143-144
144. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 350:2004;1422-1429
145. Yii NW, Khoo CT. Salvage of infected expander prostheses in breast reconstruction. Plast Reconstr Surg. 111:2003;1087-1092
146. Spear SL, Howard MA, Boehmler JH, Ducic I, Low M, Abbruzzesse MR. The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg. 113:2004;1634-1644
147. Siggelkow W, Klosterhalfen B, Klinge U, Rath W, Faridi A. Analysis of local complications following explantation of silicone breast implants. Breast. 13:2004;122-128
148. Embrey M, Adams EE, Cunningham B, Peters W, Young VL, Carlo GL. A review of the literature on the etiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesthetic Plast Surg. 23:1999;197-206
149. De Jong WH, Kallewaard M, Goldhoorn CA, et al. Long-term exposure to silicone breast implants does not induce antipolymer antibodies. Biomaterials. 25:2004;1095-1103
150. Little G, Baker J Jr. Results of closed compression capsulotomy for treatment of contracted breast implant capsules. Plast Reconstruct Surg. 65:1985;30-33
151. Henriksen T, Holmich L, Fryzek J, et al. Incidence and severity of short-term complications after breast augmentation: results from a nationwide breast implant registry. Ann Plast Surg. 51:2003;531-539
152. Cronin T, Persoff M, Upton J. Augmentional mammoplasty: complications and etiology. Owsley JQ, Peterson RA. Symposium on aesthetic surgery of the breast. 1978;Mosby, St Louis
153. Scully SJ. Augmentation mammaplasty without contracture. Ann Plast Surg. 6:1981;262-270
154. Burkhardt BR, Fried M, Schnur PL, Tofield JJ. Capsules, infection, and intraluminal antibiotics. Plast Reconstr Surg. 68:1981;43-49
155. Dubin D. The etiology, pathophysiology, predictability, and early detection of spherical scar contracture of the breast: a detailed explanation and protocol for prevention of spherical scar contracture of the breast. Annual Meeting of the American Society of Aesthetic Plastic Surgery; April 1990; Orlando, FL.
156. Shah Z, Lehman JA Jr, Tan J. Does infection play a role in breast capsular contracture? Plast Reconstr Surg. 68:1981;34-42
157. Rudolph R, Woodward M. Absence of visible bacteria in capsules around silicone breast implants. Plast Reconstr Surg. 72:1983;32-35
158. Kossovsky N, Heggers J, Parsons R, Robson M. Acceleration of capsule formation around silicone implants by infection in a guinea pig model. Plast Reconstr Surg. 73:1984;91-96
159. Netscher D, Weizer G, Wigoda P, Walker L, Thornby J, Bowen D. Clinical relevance of positive breast periprosthetic cultures without overt infection. Plast Reconstr Surg. 96:1995;1125-1129
160. Virden C, Dobke M, Stein P, Parsons C, Frank D. Subclinical infection of the silicone breast implant surface as a possible cause of capsular contracture. Aesth Plast Surg. 16:1992;173-179
161. Burkhardt BR, Dempsey PD, Schnur PL, Tofield JJ. Capsular contracture: a prospective study of the effect of local antibacterial agents. Plast Reconstr Surg. 77:1986;919-932
162. Pajkos A, Deva AK, Vickery K, Cope C, Chang L, Cossart YE. Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg. 111:2003;1605-1611
163. Burkhardt BR. Detection of subclinical infections in significant breast implant capsules. Plast Reconstr Surg. 113:2004;448
164. Netscher DT. Subclinical infection as a possible cause of significant breast capsules. Plast Reconstr Surg. 113:2004;2229-2230
165. Deva AK. Subclinical infection as a possible cause of significant breast capsules: author's reply. Plast Reconstr Surg. 113:2004;2230
166. Parsons C, Stein P, Dobke M, Virden C, Frank D. Diagnosis and therapy of subclinically infected prostheses. Surg Gynecol Obstet. 177:1993;504-506
167. Sanger J, Sheth N, Franson T. Adherence of microroganisms to breast prostheses: an in vitro study. Ann Plast Surg. 22:1989;337-342
168. Adams WP Jr, Conner WC, Barton FE Jr, Rohrich RJ. Optimizing breast-pocket irrigation: the post-betadine era. Plast Reconstr Surg. 107:2001;1596-1601
169. Birnbaum L, Hopp D, Mertens B. The role of iodine-releasing silicone implants in the prevention of spherical contractures in mice. Plast Reconstr Surg. 69:1982;956-959
170. Ransjo U, Asplund OA, Gylbert L, Jurell G. Bacteria in the female breast. Scand J Plast Reconstr Surg. 19:1985;87-89
171. Darouiche RO, Meade R, Mansouri MD, Netscher DT. In vivo efficacy of antimicrobe-impregnated saline-filled silicone implants. Plast Reconstr Surg. 109:2002;1352-1357
172. Peters W, Smith D, Fornasier V, Lugowski S, Ibanez D. An outcome analysis of 100 women after explantation of silicone gel breast implants. Ann Plast Surg. 39:1997;9-19
173. Austad ED, Rohrich RJ. Silicone implants, granulomas, and chronic infection: a causal relationship? Plast Reconstr Surg. 111:2003;1363
174. Austad E. Breast implant-related silicone granulomas: the literature and the litigation. Plast Reconstr Surg. 109:2002;1724-1730
175. Nordstrom RE. Antibiotics in the tissue expander to decrease the rate of infection. Plast Reconstr Surg. 81:1988;137-138
176. Cutando-Soriano A, Galindo-Moreno P. Antibiotic prophylaxis in dental patients with body prostheses. Med Oral. 7:2002;348-359